Pilot the roadmaps – benefit from roadmap creation mentorship by COMPASS experts!
In the roadmap co-creation labs COMPASS supported companies in outlining tailored visions, setting concrete goals, identifying gaps, and defining actions and milestones.
A limited number of SMEs now have the opportunity to participate in the piloting phase, where they have the chance to implement the sector-tailored Responsible Innovation roadmaps with mentorship from COMPASS experts. A dedicated mentoring scheme will be activated, offering dedicated networking and communication support services.
If you are active in one of the three emerging technology industries: nanotechnology, cyber security or biomedicine, and want to take part, please register for the COMPASS RI “Consulting and Mentoring Scheme” or contact us!
Why companies have joined the COMPASS Mentoring Scheme
We want to ensure that people, planet and profit grow by applying Responsible Innovation. We make sure that our innovations are challenging, fun and inclusive to all people involved. We contribute to a reduction of CO2 emissions, energy and waste. We do so in an atmosphere of trust, and use the leverage of new innovative technologies.
The COMPASS Mentoring Scheme helps us improve in all these aspects of Responsible Innovation.
Jan Hoogenraad
Director at Spoorgloren
We are keen to do the right thing, and to collaborate and network with other companies who have the same values as we do. It is essential that any innovation is performed with care to ensure all results, both direct and indirect, are of benefit to society and cause no harm.
We have already felt a benefit from the COMPASS workshops and the guidance from COMPASS will help us to move ahead and take our Responsible Innovation practises to the next level.
Emma Philpott
CEO, The IASME Consortium Ltd
Roadmap co-creation labs- the road so far
The Responsible Innovation Labs aimed to advance the understanding of Responsible Innovation in the nanotechnology, cyber security (infosec) and biomedicine sectors. The labs engaged companies, research projects, and high-level experts in a five-step series of online and offline interactive workshops to develop roadmaps towards Responsible Innovation in their field.
The labs took place between September 2017 and March 2018 and were all about co-creation and experimentation of new practices. They allowed companies to look at their own practices and methods to see what improvements can be made in order to maximise mid to long term profits or extend their markets through becoming more receptive to the needs of customers and users.
We co-created visions and roadmaps towards the integration of Responsible Innovation principles into the daily practices of SMEs. It is now time for the analysis of the roadmaps, as well as the preparation of the next steps for piloting roadmaps and tools developed by the COMPASS project!
Meet the Responsible Innovation pioneers
| Aelix Therapeutics | Ankar Pharma | Biocat | Care Respite | digital shadows | GAEM Foundation |
 |
 |
 |
 |
 |
 |
| Aelix Therapeutics is a spin-off from the IRSICAIXA institute (a major European center for AIDS research). This biotech company works on developing the first therapeutic vaccine to cure HIV infection. | Ankar Pharma is a spin-off from the Spanish National Research Council (CSIC). Its mission is to develop drugs that cure or increase the quality of life of patients suffering from neurodegenerative diseases. | Biocat acts as a strategic agent and catalyst in the Catalan healthcare and life sciences ecosystem. Its mission is to transform knowledge and technology into economic growth and to create a social impact. | Care Respite is a joint spin-off from the Computer Vision Center, Acceplan, and 3 Spanish universities (UB, UAB, UOC). Its ambient intelligent monitoring system recognizes risk events of people with reduced autonomy. | Digital Shadows monitors, manages, and remediates digital risk across the widest range of sources on the visible, deep, and dark web to protect your organization. | The GAEM Foundation supports innovative projects that can become therapeutical solutions for healing Multiple Sclerosis (MS) and for improving the quality of life of MS sufferers. |
| IASME Consortium | Manremyc | QMENTA | NOMINET | SOM Biotech | YOTI |
 |
 |
 |
 |
 |
 |
| IASME is an information assurance standard, particularly suitable for SMEs. IASME assesses and certifies organisations against the IASME Governance Standard and the Cyber Essentials Scheme. | MANREMYC aims to eradicate Tuberculosis, reaching out to most neglected populations, with a new patented supplement food made with inactivated Mycobacterium manresensis . The company holds a B Corp Certification. | QMENTAs technology is specialized on medical image analysis, scientific visualization and software and is on a mission to unlock the potential of neuroimaging with a scalable data technology platform. | NOMINET works at the heart of the internet infrastructur, offering registry services, deploying analytics to tackle cyber threats and finding new ways to connect people and devices. | SOM Biotech is a biopharmaceutical company. Its business strategy is to identify, preclinically & clinically develop and commercialize drugs to treat rare diseases with special emphasis on the neurological field. | YOTI is a London-based technology company on a mission to become the world’s most trusted identity platform. It can be used to prove your age, verify people you meet online, prove your identity to businesses, and more. |
Get involved and test our Responsible Innovation tools!
Until December 2018 you have the unique chance to sign up to test one of the sector specific Responsible Innovation Roadmaps!
Tell me more!
